<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Nephrolithiasis is an adverse effect occurring in a 3â€“7% of children treated with restricted KDs [
 <xref rid="B35-nutrients-11-01104" ref-type="bibr" class="xref">35</xref>,
 <xref rid="B36-nutrients-11-01104" ref-type="bibr" class="xref">36</xref>,
 <xref rid="B37-nutrients-11-01104" ref-type="bibr" class="xref">37</xref>], while no cases of kidney stone have been reported in adults treated with MAD and LGIT [
 <xref rid="B38-nutrients-11-01104" ref-type="bibr" class="xref">38</xref>]. Supplementation with oral potassium citrate seems to help prevent kidney stone formation [
 <xref rid="B35-nutrients-11-01104" ref-type="bibr" class="xref">35</xref>,
 <xref rid="B39-nutrients-11-01104" ref-type="bibr" class="xref">39</xref>].
</p>
